Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-642-6 | CAS number: 85-91-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- toxicity to reproduction
- Remarks:
- other: Chronic repeated dose toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from peer- reviewed journal
Data source
Reference
- Reference Type:
- publication
- Title:
- Acute and Short-term Toxicity of Methyl-N-methyl Anthranilate in Rats
- Author:
- I. F. Gaunt and M. Sharra TT P. Grasso and M. Wright
- Year:
- 1 970
- Bibliographic source:
- Food Cosmet. Toxicol. Vol. 8, pp. 359-368. Pergamon Press 1970.
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: as below
- Principles of method if other than guideline:
- Chronic repeated dose toxicity study of tets material in rats.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Methyl N-methylanthranilate
- EC Number:
- 201-642-6
- EC Name:
- Methyl N-methylanthranilate
- Cas Number:
- 85-91-6
- Molecular formula:
- C9H11NO2
- IUPAC Name:
- methyl 2-(methylamino)benzoate
- Reference substance name:
- Methyl -N-methylanthranilate
- IUPAC Name:
- Methyl -N-methylanthranilate
- Details on test material:
- - Name of test material (as cited in study report): Methylanthranilate (MMA)
- Molecular formula (if other than submission substance): C9H11NO2
- Molecular weight (if other than submission substance): 165.191 /mole
- Substance type: Organic
- Physical state: solid
- Impurities (identity and concentrations): 2 %
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- other: CFE
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF colony
- Age at study initiation: (P) x wks; (F1) x wks: No data available
- Weight at study initiation: (P) Males: x-x g; Females: x-x g; (F1) Males: x-x g; Females: x-x g: No data available
- Fasting period before study: No data available
- Housing: Animals were housed 5 rat per cage
- Diet (e.g. ad libitum): Spillers' Laboratory Small Animal Diet, ad libitum
- Water (e.g. ad libitum): Water, ad libitum
- Acclimation period: No data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data available
- Humidity (%): No data available
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): No data available
IN-LIFE DATES: From: To: No data available
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: Spillers' Laboratory Small Animal Diet
- Details on exposure:
- No data available
- Details on mating procedure:
- No data available
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- By using Pye 104 dual flame ionization chromatograph.
- Duration of treatment / exposure:
- 90 days
- Frequency of treatment:
- Daily
- Details on study schedule:
- No data available
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 300, 1200 and 3600 ppm (21, 82 and 244 mg/kg/day for the three dose levels in males and 24, 95 and 280 mg/kg/ day in females.)
Basis:
actual ingested
- No. of animals per sex per dose:
- Total: 120
0 ppm : 15 male, 15 female
300 ppm : 15 male, 15 female
1200 ppm : 15 male, 15 female
3600 ppm : 15 male, 15 female - Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Because of the small amount of flavoring lost from the test diets and its apparent palatability, the material was administered in the diet at 0, 300, 1200 and 3600 ppm
- Positive control:
- No data available
Examinations
- Parental animals: Observations and examinations:
- Clinical sign, Body Weight, Food consumption, Water Consumption, Haematology, Clinical Chemistry and Urinalysis were observed .
- Oestrous cyclicity (parental animals):
- No data available
- Sperm parameters (parental animals):
- No data available
- Litter observations:
- No data available
- Postmortem examinations (parental animals):
- Reporductive organ weight, gross pathology and histopathology were exmined.
- Postmortem examinations (offspring):
- No data available
- Statistics:
- Statistical analysis is performed by using Student's t test for the significance of Haematological examination and Absolute and relative organ weights.
- Reproductive indices:
- No data available
- Offspring viability indices:
- No data available
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- not specified
Details on results (P0)
Clinical signs:No signs of ill health were observed in treated rat during the study as compared to control.
Body weight: No effect was observed on body weight and weight gain of treated rat as compared to control.
Food consumption: No effect was observed on food consumption of treated rat as compared to control.
Test substance intake:Average intakes of were 21, 82 and 244 mg/kg/day for the three dose levels in males and 24, 95 and 280 mg/kg/ day in females.
Organ weights: When male and female rats treated with 244 and 280 mg/kg bw, Absolute and relative kidney weight was significantly increased in male and relative weight in female as compared to control.
When male and female rats treated with 82 and 95 mg/kg bw, Absolute and relative kidney weight was significantly increased in male and relative kidney, adrenals and ovaries weight in female as compared to control.
No effect on reproductive oragn weight of female gonads were observed at 288 mg/kg bw.
Gross pathology: No gross abnormalities were observed in Gonads of treated male and female rat as compared to control.
Histopathology: No histopathological changes were observed in Gonads of treated male and female rat as compared to control.
other findings:
Water consumption: No effect was observed on water consumption of treated rat as compared to control.
Haematology:
At 6 week,
When treated with 244 and 280 mg/kg bw, in male rat significant decrease were observed in hemoglobin, RBC and WBC (particularly the lymphocytes) and in female significant decrease hemoglobin were observed.
When treated with 82 and 96 mg/kg bw, in male rat significant decrease were observed in WBC (particularly the lymphocytes) and in female hemoglobin level as compared to control.
At autopsy,
No significant differences between treated and control groups were observed.
Clinical chemistry:No significant differences were observed in treated rat as compared to control.
Urinanalysis: No significant differences were observed in urine analyses of treated rat as compared to control.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 244 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: No effect on reporductive organweight, gorss pathology and histopathology
- Remarks on result:
- other: No effect on reporductive organ weight
- Dose descriptor:
- NOAEL
- Effect level:
- 288 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: No effect on reporductive organ weight, gorss pathology and histopathology
- Remarks on result:
- other: No effect on reporductive organ weight
Target system / organ toxicity (P0)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
- Other effects:
- not specified
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not specified
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not specified
Effect levels (F1)
- Dose descriptor:
- other: not specified
- Generation:
- other: not specified
- Based on:
- not specified
- Sex:
- not specified
- Basis for effect level:
- other: not specified
- Remarks on result:
- not measured/tested
Target system / organ toxicity (F1)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
- Relation to other toxic effects:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Any other information on results incl. tables
Absolute and relative organ weights of rats fed at 0-3600 ppm of the diet for 13 wk
Sex and dietary level (ppm) |
Organ weights |
Terminal body weight (g) |
|||||||||||
Brain |
Heart |
Liver |
Spleen |
Stomach |
Intestine |
Caecum |
Kidneys |
Adrenalst |
Gonads |
Pituitaryt |
Thyroid |
||
Male |
Absolute organ weight (g) |
||||||||||||
0 |
1.88 |
1.29 |
10.31 |
0.75 |
1.52 |
5.67 |
1.07 |
2.79 |
55 |
3.62 |
12 |
22 |
415 |
300 |
1.87 |
1.31 |
10.24 |
0.72 |
1.52 |
5.96 |
1.09 |
2.92 |
52 |
3.53 |
12 |
22 |
420 |
1200 |
1.85 |
1.30 |
10.49 |
0.77 |
1.50 |
5.84 |
1.01 |
2.97** |
54 |
3.57 |
12 |
23 |
42 |
3600 |
1"86 |
1-28 |
10.57 |
0'75 |
1.56 |
5.76 |
1.16 |
3.04** |
53 |
3.47 |
12 |
22 |
414 |
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
1.76 |
0.96 |
0.62 |
1.38 |
5.43 |
0.89 |
0.89 |
1.83 |
61 |
0.13 |
15 |
19 |
286 |
300 |
1.74 |
0.93 |
6.35 |
0-58 |
1.36 |
5.60 |
0.92 |
1.85 |
62 |
0.14 |
15 |
19 |
283 |
1200 |
1.76 |
0.93 |
6.25 |
0.60 |
1.32 |
5.34 |
0.89 |
1.88 |
66 |
0.15 |
15 |
20 |
27 |
3600 |
1.87 |
0.93 |
6.58 |
0.59 |
1.33 |
5.66 |
0.94 |
1.91 |
64 |
0.13 |
16 |
19 |
282 |
Male |
Relative organ weight (g/100 g body weight |
||||||||||||
0 |
0.45 |
0.31 |
2.50 |
0.18 |
0.37 |
1.37 |
0.25 |
0.67 |
13.2 |
0.87 |
2.82 |
5.26 |
|
300 |
0.44 |
0.31 |
2.44 |
0.17 |
0.36 |
1.42 |
0.25 |
0.69 |
12.4 |
0.84 |
2.85 |
5.22 |
|
1200 |
0.44 |
0.31 |
2.47 |
0.18 |
0.35 |
1.38 |
0.23 |
0.70* |
12.8 |
0.84 |
2.82 |
5.52 |
|
3600 |
0.45 |
0.31 |
2.57 |
0.18 |
0.38 |
1.39 |
0.28 |
0.73*** |
12.8 |
0.84 |
2.77 |
4.99 |
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
0.62 |
0.33 |
2.40 |
0.21 |
0.48 |
1.89 |
0.32 |
0.64 |
21.6 |
0.045 |
5.17 |
6.62 |
|
300 |
0.62 |
0.33 |
2.37 |
0.21 |
0.48 |
1.97 |
0.32 |
0.66 |
21.8 |
0.048 |
5.23 |
6.56 |
|
1200 |
0.64 |
0.34 |
2.42 |
0.22 |
0.48 |
1.94 |
0.32 |
0.69** |
24.1'* |
0.052* |
5.53 |
7.10 |
|
3600 |
0.63 |
0.33 |
2.47 |
0.21 |
0.47 |
2.00 |
0.33 |
0.68* |
22.7 |
0.046 |
5.68 |
6.56 |
|
ϮValues of absolute and relative weights of this organ are expressed in mg and mg[100 g body weight respectively.
Values are the means of groups of 15 animals and those marked with asterisks differ significantly (Student'sttest) from those of controls: *P < 0"05; **P < 0"01; ***P < 0"001.
Applicant's summary and conclusion
- Conclusions:
- NOAEL was considered to be 244 mg/kg body weight/day for male and 288 mg/kg bw for female when CFE male and female rat treated with test material orally.
- Executive summary:
In a Chronic repeated dose toxicity study, CFE male and female rat were treated with test material in the concentration of 0, 300, 1200 and 3600 ppm orally in diet equivalant to average intakes of 21, 82 and 244 mg/kg/day for males and 24, 95 and 280 mg/kg/ day for females.No signs of ill health, change in body weight,food and water consumption, Clinical chemistry and Urinanalysis were observed in treated male and female rat during the study as compared to control. At 6 week, significant decrease was observed in hemoglobin, RBC and WBC (particularly the lymphocytes) of male and female rat when treated with 82 and 244 mg/kg bw and 82 and 96 mg/kg bw treated rats. Similarly, Absolute and relative kidney weight was significantly increased in male rat and absolute and relative kidney weight , relative adrenals and ovaries weight in female when treated with 82 and 244 mg/kg bw and 82 and 96 mg/kg bw treated rats as compared to control. As no effect on reproductive oragn weight of female gonads were observed in 288 mg/kg bw, the observed change in relative organ weight of female gonads were considered to be non significant. In addition,No gross abnormalities and histopathological changes were observed in Gonads of treated male and female rat as compared to control.Therefore, NOAEL was considered to be 244 mg/kg body weight/day for male and 288 mg/kg bw for female when CFE male and female rat treated with test material orally in feed for 90 days.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.